Pfizer launches e-payment scheme for emerging markets

February 8, 2010
Sales and Marketing Pfizer, discount, em, emerging markets

Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …

Roche expands Herceptin franchise

February 8, 2010
Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer

Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …

Pfizer to personalise brain tumour vaccine

February 8, 2010
Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …

Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010
Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …

Generics firm press for ‘clear and open’ market

February 8, 2010
Sales and Marketing generics, industry

Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …

Carbogen Amcis opens large-scale high-potency API plant

February 8, 2010
Manufacturing and Production Carbogen Amcis, Dishman, India

Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …

GSK appoints Philippe Fauchet president of GSK Japan

February 8, 2010
Sales and Marketing GlaxoSmithKline, appointment, sales and marketing

GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …

Pharma manufacturing news in brief

February 8, 2010
Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners

Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …

UK swine flu leaflet

UK swine flu cases fall

February 5, 2010
Sales and Marketing h1n1, swine flu

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

Cohn and Wolfe Mike Kan

Cohn & Wolfe appoints Mike Kan

February 5, 2010
Medical Communications Cohn & Wolfe, appointment, medical communications

Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …

Recipharm charms Cobra shareholders into selling up

February 5, 2010
Manufacturing and Production Cobra, Recipharm, Wasserburger

Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …

ABPI

Barker praises OLS model

February 5, 2010
Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …

Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010
Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010
Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

Portfolio Harmony in five easy steps

February 5, 2010
Sales and Marketing product portfolio

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Zeftera problems weigh down Basilea

February 5, 2010
Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …

GSK acquires respiratory candidate

February 4, 2010
Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010
Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

Fishawack makes US acquisition

February 4, 2010
Medical Communications Nexus Communications, fishawack

Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …

The Gateway to Local Adoption Series

Latest content